These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17291752)

  • 1. Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold.
    Dodd DS; Sheriff S; Chang CJ; Stetsko DK; Phillips LM; Zhang Y; Launay M; Potin D; Vaccaro W; Poss MA; McKinnon M; Barrish JC; Suchard SJ; Murali Dhar TG
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1908-11. PubMed ID: 17291752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors.
    Guckian KM; Lin EY; Silvian L; Friedman JE; Chin D; Scott DM
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5249-51. PubMed ID: 18778938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazol-2-one derivatives.
    Wu JP; Emeigh J; Gao DA; Goldberg DR; Kuzmich D; Miao C; Potocki I; Qian KC; Sorcek RJ; Jeanfavre DD; Kishimoto K; Mainolfi EA; Nabozny G; Peng C; Reilly P; Rothlein R; Sellati RH; Woska JR; Chen S; Gunn JA; O'Brien D; Norris SH; Kelly TA
    J Med Chem; 2004 Oct; 47(22):5356-66. PubMed ID: 15481974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors.
    Lin EY; Guckian KM; Silvian L; Chin D; Boriack-Sjodin PA; van Vlijmen H; Friedman JE; Scott DM
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5245-8. PubMed ID: 18783948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry.
    Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A
    Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
    Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.
    Waelchli R; Bollbuck B; Bruns C; Buhl T; Eder J; Feifel R; Hersperger R; Janser P; Revesz L; Zerwes HG; Schlapbach A
    Bioorg Med Chem Lett; 2006 Jan; 16(1):108-12. PubMed ID: 16236504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold.
    Potin D; Launay M; Nicolai E; Fabreguette M; Malabre P; Caussade F; Besse D; Skala S; Stetsko DK; Todderud G; Beno BR; Cheney DL; Chang CJ; Sheriff S; Hollenbaugh DL; Barrish JC; Iwanowicz EJ; Suchard SJ; Dhar TG
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1161-4. PubMed ID: 15686933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.
    Cho WJ; Le QM; My Van HT; Youl Lee K; Kang BY; Lee ES; Lee SK; Kwon Y
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3531-4. PubMed ID: 17498951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines.
    Perry B; Alexander R; Bennett G; Buckley G; Ceska T; Crabbe T; Dale V; Gowers L; Horsley H; James L; Jenkins K; Crépy K; Kulisa C; Lightfoot H; Lock C; Mack S; Morgan T; Nicolas AL; Pitt W; Sabin V; Wright S
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4700-4. PubMed ID: 18644721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors.
    Holsworth DD; Jalaie M; Belliotti T; Cai C; Collard W; Ferreira S; Powell NA; Stier M; Zhang E; McConnell P; Mochalkin I; Ryan MJ; Bryant J; Li T; Kasani A; Subedi R; Maiti SN; Edmunds JJ
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3575-80. PubMed ID: 17482464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of novel glycomimetics: inhibitors of concanavalin A.
    Welch KT; Turner TA; Preast CE
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6573-5. PubMed ID: 18990567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cytotoxicity of aurilide analogs.
    Suenaga K; Kajiwara S; Kuribayashi S; Handa T; Kigoshi H
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3902-5. PubMed ID: 18583129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors.
    Ahn JH; Shin MS; Jun MA; Jung SH; Kang SK; Kim KR; Rhee SD; Kang NS; Kim SY; Sohn SK; Kim SG; Jin MS; Lee JO; Cheon HG; Kim SS
    Bioorg Med Chem Lett; 2007 May; 17(9):2622-8. PubMed ID: 17331715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, modeling, and RET protein kinase inhibitory activity of 3- and 4-substituted beta-carbolin-1-ones.
    Cincinelli R; Cassinelli G; Dallavalle S; Lanzi C; Merlini L; Botta M; Tuccinardi T; Martinelli A; Penco S; Zunino F
    J Med Chem; 2008 Dec; 51(24):7777-87. PubMed ID: 19053769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of sulfoximine based inhibitors for HIV-1 protease.
    Raza A; Sham YY; Vince R
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5406-10. PubMed ID: 18829317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective synthesis of 15- and 16-substituted isosteviol derivatives and their cytotoxic activities.
    Wu Y; Dai GF; Yang JH; Zhang YX; Zhu Y; Tao JC
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1818-21. PubMed ID: 19223180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic control of allosteric antagonism of leukocyte function antigen-1 and intercellular adhesion molecule-1 interaction.
    Nam K; Maiorov V; Feuston B; Kearsley S
    Proteins; 2006 Aug; 64(2):376-84. PubMed ID: 16705652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure based optimization of novel Akt inhibitors.
    Lippa B; Pan G; Corbett M; Li C; Kauffman GS; Pandit J; Robinson S; Wei L; Kozina E; Marr ES; Borzillo G; Knauth E; Barbacci-Tobin EG; Vincent P; Troutman M; Baker D; Rajamohan F; Kakar S; Clark T; Morris J
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3359-63. PubMed ID: 18456494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors.
    Shafer CM; Lindvall M; Bellamacina C; Gesner TG; Yabannavar A; Jia W; Lin S; Walter A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4482-5. PubMed ID: 18672368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.